Alcon Inc. v. Padagis Israel Pharmaceuticals Ltd.
| ALCON INC., ALCON VISION, LLC and ALCON LABORATORIES, INC. |
| PADAGIS ISRAEL PHARMACEUTICALS LTD., PADAGIS US LLC and PADAGIS LLC |
| 25-1577 |
| March 24, 2025 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 24, 2025. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Note to File: The following cases are consolidated: 25-1515 Lead with 25-1577 Cross-Appeal. The parties must file all documents in the lead appeal only. [1077410] [25-1515, 25-1577] [JSP] [Entered: 03/24/2025 12:27 PM] |
| Filing 1 Appeal docketed. Received: 03/20/2025. [1077406] Entry of Appearance due 04/07/2025. Certificate of Interest is due on 04/07/2025. Docketing Statement due 04/07/2025. Appellant/Petitioner's brief is due 05/23/2025. [JSP] [Entered: 03/24/2025 12:24 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
